Don't Overlook The Risks Of Innovative Clinical Trials

By Nathalie Smyth, Daniel Brettler, Michele Fields, & Camille Hepsworth

The clinical trials landscape is evolving at an unprecedented pace, being both propelled and incentivized by the global race to advance the COVID-19 vaccines. Advancements in AI and machine learning (ML) for data collection and interpretation and a move toward virtual and adaptive trials and use of real-world data (RWD) have paved the way for the development of novel data collection techniques and analysis. These advancements also could increase the threat of cyberattacks and malicious hacking of private medical data.